Background and Purpose-Using a nationwide population-based data set from Taiwan, this study investigated the relationship between neovascular age-related macular degeneration (AMD) and the risk of stroke over a 5-year period. Method-The study cohort comprised 209 patients who received treatment for AMD between 1999 and 2001. We randomly selected 1045 subjects matched with the study cohort in terms of age and gender for comparison. Cox proportional hazard regressions were performed to compare the 5-year stroke-free survival rate. Results-Among the sampled patients, 142 patients (11.3%) had strokes during the 5-year follow-up period, 38 (18.2% of the patients with AMD) from the study cohort and 104 (9.9% of patients in the comparison cohort) from the comparison cohort. After adjusting for the patient's age, gender, monthly income, level of urbanization, and the geographic region of the community in which the patient resided and comorbidities, the hazard ratio for stroke during the follow-up period was 2.01 (Pϭ0.001) times greater for patients with AMD than for patients without AMD. The adjusted hazard ratio for stroke during the follow-up period was 2.21 (Pϭ0.001) times higher for patients with AMD Ն65 years old compared with the same age group in the comparison cohort. However, no significant difference was observed in the risk of stroke between patients with AMD Ͻ65 years of age and comparison patients in the same age group. Conclusion-We conclude that neovascular AMD is associated with a higher risk of stroke for patients with AMD Ն65 years old. (Stroke. 2010;41:613-617.)
A ge-related macular degeneration (AMD) is a degenerative condition affecting the macula or central area of the retina in elderly people. Early AMD is marked by the presence of soft drusen and/or retinal pigment abnormality (hyper-and hypopigmentation). Late AMD includes 2 forms, nonneovascular (dry) AMD and neovascular (wet) AMD. Despite new medical and surgical interventions, AMD remains a leading cause of vision loss in elderly people all over the world. [1] [2] [3] [4] [5] [6] [7] There have been a number of studies that have examined a possible association between AMD and stroke, including the Cardiovascular Health Study (CHS) 8 and the Atherosclerosis Risk in Communities Study (ARIC). 9 Although the CHS found early AMD was associated with cerebral white matter disease on MRI images (OR, 1.50; 95% CI, 1.05 to 2.16) 8 and ARIC found an almost 2-fold risk of stroke over 10 years, (hazard ratio [HR], 1.87; 95% CI, 1.21 to 2.88), 9 sample sizes in both studies were small and lacked sufficient statistical power to clarify the relationship between late AMD and stroke. 8, 9 A recent CHS study indicated that neither early nor late AMD was associated with stroke. 10 Moreover, US Medicare beneficiaries with neovascular AMD had a rate of inpatient ischemic stroke similar to that of matched control subjects. 11 However, in the Blue Mountains Eye Study (BMES), Tan et al reported that late AMD predicted 10-fold higher stroke mortality in people Ͻ75 years of age. 12 Whether late AMD is related to stroke is thus still unproven.
Using a nationwide population-based data set from Taiwan, this study investigated the relationship between neovascular AMD and the risk of stroke over a 5-year follow-up period.
Methods

Database
This study used the "Longitudinal Health Insurance Database (LHID)" released by the Taiwan National Health Research Institute (NHRI). Taiwan began its single-payer National Health Insurance (NHI) program in 1995 to provide affordable health care for all the island's residents. As of 2007, 22.6 million of Taiwan's 22.96 million people were enrolled in this program, amounting to 98.4% of the island's population. The Taiwan NHRI created the LHID, which consists of 1 000 000 subjects, by systematically selecting a representative database from the 25.68 million enrollees listed in the 2005 Registry of Beneficiaries. All the registration and claims data for these 1 000 000 individuals collected by the NHI Program constitute the LHID. There is no significant difference between the patients in the LHID and the original medical claims for all enrollees under the NHI program in gender distribution, age distribution, or average payrollrelated insurance payment amount. Consequently, the LHID offers an excellent opportunity to explore the risk of stroke among patients with neovascular AMD.
Because the data set used in this study consists of deidentified secondary data released to the public for research purposes, the study was exempt from full review by the Institutional Review Board.
Study Sample
We selected patients who visited ambulatory care centers receiving a principal diagnosis of neovascular AMD (International Classification of Diseases, 9th Revision, Clinical Modification codes 362.42, 362.43, 362.52, or 362.53) from January 1, 1999, to December 31, 2001 (nϭ302) as our study cohort. We excluded patients who had visited ambulatory care centers for the treatment of AMD before the year 1999 (1996 to 1998) to increase the likelihood of selecting only new cases (nϭ83). We also excluded patients who had been diagnosed with stroke (International Classification of Diseases, 9th Revision, Clinical Modification codes 430 to 438) before 1999 (nϭ10). Ultimately, 209 patients with AMD were included in the study cohort.
Our comparison cohort was extracted from the remaining patients in the LHID. We selected their first ambulatory care visits occurring in 2001 as their index ambulatory care visit. We excluded patients who had been diagnosed as having AMD or stroke before 2001. We then randomly selected 1045 subjects (5 for every patient in the study cohort) matched in terms of age (as a continuous variable) and gender with the SAS program (Version 8.2; SAS System for Windows).
Each patient then was individually tracked for 5 years from their index ambulatory care visit to distinguish all patients who had strokes. All stroke cases are admitted to an emergency room in Taiwan, even a person who dies at home or on the way to the emergency room. In Taiwan, all dead patients, especially patients who died suddenly, need to have their cause of death diagnosed by a physician to allow their families to apply for a death certificate. So even patients with stroke who died at home are sent to the emergency room to obtain a cause of death. The database used in this study actually covers all stroke events in Taiwan.
Statistical Analysis
All analyses in this study were performed with the SAS statistical package. We used Pearson 2 tests to explore differences between the 2 cohorts in terms of sociodemographic characteristics, select comorbid medical disorders (hypertension, diabetes, coronary heart disease [CHD], and hyperlipidemia), and the incidence of stroke. The Kaplan-Meier method and log-rank test were performed to estimate the 5-year stroke-free survival rate and to examine differences in the risk of stroke between the 2 cohorts.
In addition, Cox proportional hazard regressions were also carried out to calculate the 5-year survival rate after adjusting for potential confounders. Potential confounders included in this study were patient's age, gender, monthly income, level of urbanization (5 levels with Level 1 referring to the "most urbanized" and Level 5 referring to the "least urbanized" communities), and the geographical location of the community in which the patient resided (northern, central, eastern, and southern Taiwan) as well as whether a patient had hypertension, diabetes, CHD, or hyperlipidemia. We selected NT $15 840 as the first income level cutoff point because this amount is the government-stipulated minimum wage for full-time employees in Taiwan. A 2-sided probability value of Ͻ0.05 was used to determine the significance of predictors in the models.
Results
Of the total sample of 1254 patients, the mean age was 62.7 (SDϭ16.8 years), and 60.3% were male. Table 1 shows the distribution of demographic characteristics and select comorbid medical disorders for patients with AMD and patients in the comparison cohort. After matching for gender and age, it reveals that patients with AMD were more likely to have comorbid diabetes (Pϭ0.001) and CHD (PϽ0.001) at the time of their index ambulatory care visits compared with the patients in the comparison cohort. Interestingly, it also shows that patients with AMD had a greater tendency to reside in less urbanized communities than the comparison cohort (PϽ0.001). Table 2 describes the distribution of stroke between the 2 cohorts. Among the sampled patients, 142 patients (11.3%) had strokes during the 5-year follow-up period, 38 (18.2% of the patients with AMD) from the study cohort and 104 (9.9% of comparison patients) from the comparison cohort. The log-rank test suggests that patients with AMD had significantly lower 5-year stroke-free survival rates than patients in the comparison cohort (PϽ0.001). Table 2 also illustrates the crude and adjusted HRs for stroke by cohort. Patients with AMD were more likely to have a stroke during the 5-year follow-up period compared with patients in the comparison cohort (HRϭ2.42, 95% CIϭ1.47 to 3.98, PϽ0.001). Similarly, after adjusting for the patient's age, gender, monthly income, hypertension, diabetes, CHD, hyperlipidemia, level of urbanization, and the geographical location of the community in which the patient resided, the HR of having a stroke during the follow-up period was 2.01 (95% CIϭ1.34 to 3.02, Pϭ0.001) for patients with AMD compared with the comparison cohort. Table 3 shows the crude and adjusted HRs for stroke from further analyses stratified by patient gender and age. Among male and female patients, the adjusted hazard of stroke during the 5-year follow-up period was 1.98 (95% CIϭ1.17 to 3.32, Pϭ0.010) and 2.07 (95% CIϭ1.08 to 3.95, Pϭ0.028) times greater, respectively, for those with AMD than for those without. We further analyzed the risk of stroke for patients with AMD by age. We found that the adjusted HR for stroke during the 5-year follow-up period was 2.21 (95% CIϭ1.37 to 3.56, Pϭ0.001) times higher for AMD patients Ն65 years old than for the same age group in the comparison cohort. However, no significant difference in the risk of stroke was observed between patients with AMD Ͻ65 years old and the same age group in the comparison cohort.
Discussion
Our study showed that patients with neovascular AMD were more likely to develop a stroke during the 5-year follow-up period than those in the comparison cohort (18.2% versus 9.9%, PϽ0.001). The association was independent of age, gender, diabetes, hypertension, CHD, hyperlipidemia, renal disease, monthly income, urbanization level, and geographic region (adjusted HRϭ2.01, 95% CIϭ1.34 to 3.02, Pϭ0.001).
There have been a number of studies that have examined a possible association between late AMD and stroke. In ARIC, Wong et al draw no conclusion about the association owing to insufficient late-stage AMD cases (Nϭ10). 9 In CHS, Sun et al showed that patients with late-stage AMD have a higher 7-year incidence of stroke (13.79% [4 of 29 cases] versus 9.89%). 10 In BMES, Tan et al reported that late-stage AMD predicted 10-fold higher stroke mortality in patients Ͻ75 years old (relative risk, 10.21; 95% CIϭ2.39 to 43.60; 22.2% [2 of 9 cases] versus 1.4%), but the sample for this age group was small. 12 Two reports based on US Medicare data showed inconsistent results. Liao et al reported that neovascular AMD was associated with higher adjusted 2-year incidence of stroke (8.15% versus 6.35%; OR 1.31, 95% CIϭ1.26 to 1.36), 13 but Alexander et al reported that Medicare beneficiaries with neovascular AMD had an annual rate of inpatient ischemic stroke similar to that of matched control subjects (3.5% versus 3.6%). 11 Based on a representative database and sufficient neovascular AMD case numbers (Nϭ209), our results are compatible with most previous reports, supporting an association between neovascular AMD and a higher incidence of stroke. There are several possible mechanisms for the association between AMD and stroke, including atherosclerosis, inflammation, and genetic factors. A risk factor for stroke, atherosclerosis, may also be the mechanism for AMD owing to its effect on the choroidal circulation or because lipids are deposited in the Bruch membrane. 14 -16 The association between AMD and stroke also seems to fit nicely into the model of chronic inflammation as the primary insult. 17 Individuals who possess a certain variant of the complement factor H (CFH) gene are at increased risk of developing AMD. The CFH gene is involved in regulating the alternate complement pathway. The proteins encoded by this variant increase AMD risk by failing to bind to receptors on the cells on the retina and the choroid, which prevents them from inhibiting the pathway. 18 Complement activation seen in atherosclerotic lesions in cerebral vascular disease 19 and complement factor H variants in AMD 20 seem to suggest a possible link. 17 There is another possible explanation for the positive correlation in our results between neovascular AMD and stroke. Chinese have a higher percentage of a particular form of neovascular AMD that may have a more vascular etiology, that is, polypoidal choroidal vasculopathy (PCV). Wen et al reported 22 .3% (37 of 166) of their patients in China initially suspected of having exudative AMD were ultimately diagnosed as having PCV, 21 whereas Yannuzzi et al diagnosed PCV in only 13 (7.8%) of 167 consecutive patients with presumed neovascular AMD in New York. 22 The characteristic clinicopathologic findings in polypoidal choroidal vasculopathy revealed hyalinization of choroidal vessels, like arteriosclerosis. 23 Whether there is a positive relationship between PCV and stroke is still unknown. Because we cannot differentiate PCV from the classical neovascular AMD cases using our International Classification of Diseases, 9th Revision, Clinical Modification-based database, we cannot rule out the possibility that the positive correlation between neovascular AMD and stroke comes from the ethnic difference in PCV occurrence.
Antivascular endothelial growth factor therapy has become the treatment of choice for many types of neovascular AMD. Some reports suggest antivascular endothelial growth factor may increase the risk of stroke. 24 -28 Our results showed that patients with neovascular AMD bear a higher stroke risk, so they may need to be monitored closely if receiving antivascular endothelial growth factor therapy. However, more large-scale population-based studies confirming a link between neovascular AMD and stroke would be needed before such recommendations can be made.
The findings of this study need to be interpreted mindful of the following limitations. First, the diagnoses of neovascular AMD, stroke, or other comorbid medical conditions that are totally dependent on International Classification of Diseases codes may be less accurate than those obtained through a standardized procedure. This is a major limitation of this study compared with studies that use standardized examinations of patients. However, the NHI Bureau of Taiwan randomly samples a fixed percentage of claims from every hospital and randomly interviews patients and reviews charts each year to verify the diagnosis validity and quality of care. Any hospital with outlier charges or outlier practice patterns, or which is suspected of malpractice, faces the risk of an audit and subsequent heavy penalties by the NHI Bureau if discrepancies, overcharging, and malpractice are discovered. We limited our study sample to patients with neovascular AMD, because its clinical signs (the presence of exudates, hemor- rhages, or retinal detachment) are obvious and diagnoses straightforward and not prone to misclassification for different doctors. For patients with early AMD and those with geographic atrophy, there tend to be more inconsistent classifications among different ophthalmologists. Owing to a lack of clinical validation of our claims data, we did not apply our analysis to patients with early AMD and those with geographic atrophy. Second, data on some variables such as smoking, dietary habits, and body mass index, which might contribute to stroke, are not available in this database. In addition, blood pressure and blood glucose level data are also not available. Simply including hypertension, CHD, hyperlipidemia, and diabetes in the model might not adequately adjust for the confounding effects of blood pressure and blood glucose levels; thus, these factors may have compromised our findings. Third, Ͼ98% of the residents in Taiwan are of Chinese ethnicity. The ability to generalize the results to other racial/ethnic groups is unclear given that stroke in Chinese/Asians might not be completely the same as stroke in other ethnic groups. Finally, our data only allowed us to trace the medical history of the sampled patients back to the year 1996. We cannot be certain that patients in the study and comparison group had no AMD or stroke before 1996, and this could have compromised our findings. In summary, this population-based study has demonstrated that neovascular AMD carries a higher risk for the development of stroke after adjusting for possible confounding factors. Further studies are needed to see if our data can be applied to other regions or races and to clarify the underlying pathophysiological mechanisms behind the association of neovascular AMD with stroke.
